Are you ready to start a new Obliteride team — or bring your team back this year? Join us on Fred Hutch's Seattle campus for our Team Captain Kickoff! You’ll hear from fellow team captains about how ...
A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...
Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...
As we near the five-year mark since the start of the COVID-19 pandemic, the healthcare community is still wrestling with the psychological fallout of being on the frontlines of a global crisis. The ...
Although you’re probably not a virologist, chances are you know a thing or two about herpes simplex virus (HSV), which is estimated to infect roughly two-thirds of the world’s population and causes ...
Blood and bone marrow transplantation (also known as hematopoietic cell transplantation, or HCT) was developed at Fred Hutch nearly 50 years ago to cure leukemias and other diseases of the immune ...
Vaccines are arguably one of the most important medical innovations in human history. When it comes to which diseases have successfully been targeted with vaccines, however, the playing field is far ...
How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...
We often think of blood as the uniform red liquid encountered after a kitchen accident or at the doctor’s office. While this is true, on a microscopic level blood is made up of highly heterogeneous ...
If you have ever walked into a health store and stared at the rows of dietary supplements—each promising better health, more energy, or a stronger immune system—you are not alone. In fact, millions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback